These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3959742)

  • 1. [Characteristics and the use of blood transfusions and blood components in patients with hemostasis disorders. I. Transfusion of blood and plasma].
    Grgicević D; Pistotnik M
    Lijec Vjesn; 1986; 108(2-3):92-5. PubMed ID: 3959742
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics and use of blood transfusion and blood components in the treatment of patients with hemostasis disorders: II. Levels of coagulation factors].
    Grgicević D; Pistotnik M
    Lijec Vjesn; 1986 Jun; 108(6):274-7. PubMed ID: 3724356
    [No Abstract]   [Full Text] [Related]  

  • 3. Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.
    de Alarcon P; Benjamin R; Dugdale M; Kessler C; Shopnick R; Smith P; Abshire T; Hambleton J; Matthew P; Ortiz I; Cohen A; Konkle BA; Streiff M; Lee M; Wages D; Corash L
    Transfusion; 2005 Aug; 45(8):1362-72. PubMed ID: 16078927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.
    Beck KH; Mortelmans Y; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1994; 32():440-4. PubMed ID: 9422123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion therapy in acquired coagulopathies.
    Humphries JE
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1181-201. PubMed ID: 7860444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications of the different components of blood and outcome of transfusion practices in postpartum hemorrhage].
    Ricat R; Palot M
    Cah Anesthesiol; 1994; 42(3):385-9. PubMed ID: 7812867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Status of "blood coagulation active human citrate plasma" within the scope of blood component therapy].
    Wegener S; Wilms K; Schlaack P; Roewer J
    Z Arztl Fortbild (Jena); 1987; 81(22):1151-4. PubMed ID: 3328435
    [No Abstract]   [Full Text] [Related]  

  • 8. [Directions for blood component therapy in blood coagulation disorders].
    Rasche H
    Klin Anasthesiol Intensivther; 1980; 21():136-51. PubMed ID: 6779052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemostasis disorders and their correction in the early postoperative period in patients with pulmonary diseases].
    Minina MN; Sinitsin MA
    Probl Tuberk; 1994; (3):24-6. PubMed ID: 7937666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic indications for platelets, plasma and plasma derivatives in the neonate.
    Kevy SV
    Mead Johnson Symp Perinat Dev Med; 1986; (28):55-60. PubMed ID: 3333267
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modern methods for correcting thrombocytic hemostasis].
    Matveev SA
    Vestn Khir Im I I Grek; 1989 Oct; 143(10):153-6. PubMed ID: 2698532
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood component therapy for abnormalities of hemostasis in liver disease.
    Glassman AB
    Conn Med; 1972 Oct; 36(10):572-5. PubMed ID: 5086117
    [No Abstract]   [Full Text] [Related]  

  • 13. [Disorders of hemostasis. Diagnosis and therapy].
    Pericoli Ridolfini F
    Policlinico Prat; 1972 Feb; 79(3):81-104. PubMed ID: 5012861
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haemostaseological aspects of perioperative blood management].
    Scherer RU
    Zentralbl Chir; 2003 Jun; 128(6):473-80. PubMed ID: 12865952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation disorders in the ICU.
    Marks PW
    Clin Chest Med; 2009 Mar; 30(1):123-9, ix. PubMed ID: 19186284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood plasma fractions in the management of coagulation disorders. I. Fibrinogen substitution].
    Richter K
    Z Gesamte Inn Med; 1967 May; 22(10):296-9. PubMed ID: 5586060
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications and transfusion of coagulation-active blood fractions].
    Mueller-Eckhardt C; Heinrich D; Lasch HG
    Z Prakt Anasth; 1970 Dec; 5(6):401-18. PubMed ID: 4256253
    [No Abstract]   [Full Text] [Related]  

  • 18. The blood bank: from provider to partner in treatment of massively bleeding patients.
    Johansson PI
    Transfusion; 2007 Aug; 47(2 Suppl):176S-181S; discussion 182S-183S. PubMed ID: 17651347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood: use and abuse of whole blood and fractions.
    Saidi P
    Clin Ther; 1983; 5(4):327-34. PubMed ID: 6871916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital disorders of hemostasis. Diagnosis and treatment].
    Rolović Z
    Bilt Hematol Transfuz; 1982; 10(2-3):101-8. PubMed ID: 6927290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.